4/A//SEC Filing
Arbet-Engels Christophe 4/A
Accession 0001628280-24-007711
CIK 0001501697other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:52 PM ET
Size
6.2 KB
Accession
0001628280-24-007711
Insider Transaction Report
Form 4/AAmended
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Appreciation Right
2024-02-13+180,816→ 180,816 totalExercise: $0.92Exp: 2034-02-13→ Common Stock (180,816 underlying)
Footnotes (2)
- [F1]This Form 4 amendment is being filed to correct the number of stock appreciation rights awarded to the Reporting Person on February 13, 2024. The original Form 4 filed on February 16, 2024 inadvertently reported the number of stock appreciation rights awarded as 475,831 due to an administrative error.
- [F2]The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001802615
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:52 PM ET
- Size
- 6.2 KB